Citation Impact
Citing Papers
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
COL25A1 triggers and promotes Alzheimer’s disease-like pathology in vivo
2009
Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
2018
Amyloid‐ß‐directed immunotherapy for Alzheimer's disease
2014
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
2011 Standout
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
2016
Comparisons with Amyloid-β Reveal an Aspartate Residue That Stabilizes Fibrils of the Aortic Amyloid Peptide Medin
2015
The glymphatic pathway in neurological disorders
2018 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Genetic association to the amyloid plaque associated protein gene COL25A1 in Alzheimer's disease
2008
Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid Deposition
2011
Aβ43 is more frequent than Aβ40 in amyloid plaque cores from Alzheimer disease brains
2009
Amyloid β‐peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease
2004
Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils
2010
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Inhibition of Amyloid Formation
2012
Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
2012
Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
2016
Whole-Genome Sequencing of a Healthy Aging Cohort
2016
The Collagen Family
2010 Standout
Prion-like aggregates: infectious agents in human disease
2010
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Alzheimer's disease
2016 Standout
The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
2018
Survey of the year 2003 commercial optical biosensor literature
2004
Collagens
2009
The Amyloid State of Proteins in Human Diseases
2012 Standout
Survey of the year 2005 commercial optical biosensor literature
2006
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
2012 Standout
The amyloid state and its association with protein misfolding diseases
2014 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
The evolution of gene expression levels in mammalian organs
2011 StandoutNatureNobel
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro
2013 StandoutNobel
New ELISAs with high specificity for soluble oligomers of amyloid β‐protein detect natural Aβ oligomers in human brain but not CSF
2013
The extracellular matrix at a glance
2010 Standout
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Works of Linda Söderberg being referenced
Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease
2022
Amyloid‐β protofibril levels correlate with spatial learning in Arctic Alzheimer’s disease transgenic mice
2009
Molecular Identification of AMY, an Alzheimer Disease Amyloid-Associated Protein
2003
Characterization of the Alzheimer's Disease-associated CLAC Protein and Identification of an Amyloid β-Peptide-binding Site
2004
Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons
2016
Collagenous Alzheimer amyloid plaque component assembles amyloid fibrils into protease resistant aggregates
2005
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
2009
Unwinding fibril formation of medin, the peptide of the most common form of human amyloid
2007
Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain
2013
Analysis of Single Alzheimer Solid Plaque Cores by Laser Capture Microscopy and Nanoelectrospray/Tandem Mass Spectrometry
2006
Rapid amyloid‐β oligomer and protofibril accumulation in traumatic brain injury
2017
The Murine Version of BAN2401 (mAb158) Selectively Reduces Amyloid-β Protofibrils in Brain and Cerebrospinal Fluid of tg-ArcSwe Mice
2014
CLAC Binds to Aggregated Aβ and Aβ Fragments, and Attenuates Fibril Elongation
2005